Tag: FAS Russia

Federal Antimonopoly Service (the FAS Russia) is an authorized federal executive body, which is carrying out its functions with regard to the approval of the regulatory legal acts and control over compliance with the antimonopoly legislation, legislation in the field of natural monopolies’ activity, in the field of state regulation of prices (tariffs) for the goods (services), advertising, foreign investments in the business entities of strategic importance for the Russian national defence and state security, control in the field of state defence order, purchases of goods, works and services for the state and municipal needs and procurement of goods, works and services by certain legal entities, as well as with regard to the approval of closed methods for selection of suppliers (contractors, performers).

Importance of Introducing Forced Licensing in Russia

Head of FAS Department for Social Sphere and Trade was a speaker at the Gaidar Forum where he talked about the importance of introducing forced licensing. Many international experts and scholars unde...

Reference pricing in Russia corresponds best practices of price regulation

Speaking at OECD Competition Committee in Paris, Deputy Head of FAS discussed a set of FAS measures towards reducing the maximum ex-works manufacturer prices registered in Russia for medicine to the m...

FAS Russia suggests to optimize the medical equipment market

medical devices
On 26 November 2018, the working group on Competition and Regulation of OECD Competition Committee held a Round Table on “Developing State-Financed Healthcare Market”.

FAS Russia uncovered a new cartel in public drug procurement

The Federal Antimonopoly Service of the Russian Federation opened the case based on the monitoring of public drug and medical products procurement. 'Axonmed' Ltd., 'Device' Ltd., 'InterMed' Ltd., '...

Medical products sector in Russia will be transformed

medical devices
The Federal Antimonopoly Service of Russia (FAS) and International Medical Devices Manufacturers Association (IMEDA) discussed the Road Map for developing competition in healthcare.

FAS Russia and Rosfinmonitoring signed a protocol against cartel agreements

fas russia
On 17 August 2018, the Federal Antimonopoly Service and the Federal Financial Monitoring Service signed an Additional Protocol to the Agreement on Information Interaction on exposing cartels.

Damages from cartel agreements amount up to 2% of Russian GDP

Head of the FAS Russia Anti-Cartel Department, Andrey Tenishev, took part in a coordination meeting in Nizhny Novgorod.

Inflation rate should be considered during drug registration procedure in Russia

The Federal Antimonopoly Service draws the attention of owners or holders of registration certificates of medicines included in the list of vital and essential drugs (VED).

AstraZeneca cut prices for socially important drugs in Russia by 12-92%

fas russia
The maximum ex-works prices for 11 trade names (8 INNs) of vital and essential drugs have been reduced within a short period of time. This price reduction ranged from 12 to 92 percent.

Relations of pharma companies with medical specialists should be regulated

nizhegorodcev fas russia
Timofey Nizhegorodtsev, the Head of the Department for Control over Social Sphere and Trade of Federal Antimonopoly Service (FAS) of Russia, spoke about the competition in the pharmaceutical market.

FAS Russia managed to reduce prices for Biperiden medicines

drug licensing
The Ninth Arbitration Court of Appeal confirmed the decision of the first instance court to invalidate the decisions of the Federal Tariff Service of Russia adopted in 2010 on approval of maximum ex-works prices for Akineton.

Russia may enact its register of interchangeable medicines from January 1, 2019

Russian Ministry of Health completed its work on the bill to amend the Federal Law “On Circulation of Medicines” which provides, in particular, for the establishment of a register of interchangeable drugs.

FAS will inspect large pharmaceutical companies once in 5 years

The Russian Government signed a Decree that approved the criteria for assigning specific risk categories to legal entities and individual entrepreneurs.

SPICs should involve the transfer of unique technologies

fas russia
“Special Investment Contract cannot provide guarantees for the implementation of unfair activities,” said Timofey Nizhegorodtsev, the Head of the Department for Control over Social Sphere and Trade of FAS of Russia.

FAS of Russia identified unjustified 35% overpricing of Tyverb

FAS Russia
In April 2017, the FAS Russia initiated a case on the grounds that Novartis Pharma had violated Clause 1 of Part 1 of Article 10 of the Law on Protection of Competition

FAS will support Russian manufacturers in the registration of prices

The head of Federal Antimonopoly Service of Russia Igor Artemyev met with the executives of Pharmstandard PJSC and BIOCAD CJSC